Zobrazeno 1 - 7
of 7
pro vyhledávání: '"SeungJu Jackie Oh"'
Autor:
Sacha C. Hauc, BS, BA, MPH, Kirby L. Mateja, BS, Aaron S. Long, BS, Joshua Z. Glahn, BA, Adrian R. Acuna Higaki, BS, MRes, Jean Carlo Rivera, BS, Jacqueline M. H. Ihnat, BS, Thayer Mukherjee, MD, SeungJu Jackie Oh, MD, Michael Alperovich, MD, MSc, FACS
Publikováno v:
Plastic and Reconstructive Surgery, Global Open, Vol 10, Iss 9, p e4521 (2022)
Background:. Facial feminization surgery (FFS) is an integral aspect of gender-affirming surgery (GAS) for individuals seeking to align secondary sex characteristics and gender identity. Despite the importance of FFS in treating gender dysphoria, cur
Externí odkaz:
https://doaj.org/article/f8aafdc92e93437789f381b6faec6b08
Autor:
SeungJu Jackie Oh, Paris D. Butler
Publikováno v:
Annals of Surgical Oncology. 30:8-9
Autor:
Janice F. Lalikos, Melissa McCarthy, SeungJu Jackie Oh, Victoria Irene Prete, Jorge Lujan-Hernandez, D. Stamer, Garrick Gu
Publikováno v:
Journal of burn careresearch : official publication of the American Burn Association. 42(4)
Burn depth is a critical factor in determining the healing potential of a burn as the extent of injury ultimately guides overall treatment. Visible-Light Hyperspectral Imaging is an FDA-approved, noninvasive, and noncontrast imaging technology that u
Autor:
SeungJu Jackie Oh, Xiaoduo Fan
Publikováno v:
Schizophrenia research. 222
Autor:
SeungJu Jackie Oh, Xiaoduo Fan
Publikováno v:
CNS drugs. 33(6)
A growing body of literature has elucidated the involvement of the central renin–angiotensin system (RAS) in various neuropsychiatric diseases. While consensus on the exact mechanism of the central RAS in schizophrenia pathophysiology does not curr
Publikováno v:
Translational Cancer Research. 5:327-329
Immunotherapy has increasingly proven to be a key treatment modality that can make a significant impact on the lives of many cancer patients. In particular, immune checkpoint inhibitors targeting the programmed cell death protein 1 (PD-1) pathway hav
Publikováno v:
Expert opinion on investigational drugs. 25(6)
Esophageal cancer is the third most common cancer of the gastrointestinal tract. Despite new therapies, the prognosis for patients with these cancers remains poor with 5-year survival rates lower than 15%. Recently, immunotherapy has increasingly gai